Systemic effects of ionizing radiation at the proteome and metabolome levels in the blood of cancer patients treated with radiotherapy: the influence of inflammation and radiation toxicity

References

• Alsbeih G, Story MD, Maor MH, Geara FB, Brock WA. 2003. Chromosomal fragility syndrome and family history of radiosensitivity as indicators for radiotherapy dose modification. Radiother Oncol. 66:341–344.
   PubMed Web of Science ®Google Scholar
• Alsner J, Andreassen CN, Overgaard J. 2008. Genetic markers for prediction of normal tissue toxicity after radiotherapy. Semin Radiat Oncol. 18:126–135.
   PubMed Web of Science ®Google Scholar
• Andreassen CN. 2010. Searching for genetic determinants of normal tissue radiosensitivity – are we on the right track? Radiother Oncol. 97:1–8.
   PubMed Web of Science ®Google Scholar
• Andreassen CN, Alsner J. 2009. Genetic variants and normal tissue toxicity after radiotherapy: a systematic review. Radiother Oncol. 92:299–309.
   PubMed Web of Science ®Google Scholar
• Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, Mignot G, Maiuri MC, Ullrich E, Saulnier P, et al. 2007. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med. 13:1050–1059.
   PubMed Web of Science ®Google Scholar
• Balkwill F, Mantovani A. 2001. Inflammation and cancer: back to Virchow? The Lancet. 357:539–545.
   PubMed Web of Science ®Google Scholar
• Barcellos-Hoff MH. 1998. How do tissues respond to damage at the cellular level? The role of cytokines in irradiated tissues. Radiat Res. 150: S109–S120.
   PubMed Web of Science ®Google Scholar
• Barnett GC, Coles CE, Elliott RM, Baynes C, Luccarini C, Conroy D, Wilkinson JS, Tyrer J, Misra V, Platte R, et al. 2012. Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study. Lancet Oncol. 13:65–77.
   PubMed Web of Science ®Google Scholar
• Barnett GC, West CM, Dunning AM, Elliott RM, Coles CE, Pharoah PD, Burnet NG. 2009. Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat Rev Cancer. 9:134–142.
   PubMed Web of Science ®Google Scholar
• Becciolini A, Giannardi G, Cionini L, Porciani S, Fallai C, Pirtoli L. 1984. Plasma amylase activity as a biochemical indicator of radiation injury to salivary glands. Acta Radiol Oncol. 23:9–14.
   PubMed Web of Science ®Google Scholar
• Bentzen SM. 2006. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer. 6:702–713.
   PubMed Web of Science ®Google Scholar
• Bentzen SM. 2008. From cellular to high-throughput predictive assays in radiation oncology: challenges and opportunities. Semin Radiat Oncol. 18:75–88.
   PubMed Web of Science ®Google Scholar
• Bertho JM, Demarquay C, Frick J, Joubert C, Arenales S, Jacquet N, Sorokine-Durm I, Chau Q, Lopez M, Aigueperse J, et al. 2001. Level of Flt3-ligand in plasma: a possible new bio-indicator for radiation-induced aplasia. Int J Radiat Biol. 77:703–712.
   PubMed Web of Science ®Google Scholar
• Boguszewicz Ł, Hajduk A, Mrochem-Kwarciak J, Skorupa A, Ciszek M, Heyda A, Składowski K, Sokół M. 2016. 1H NMR based metabolomic approach to monitoring of the head and neck cancer treatment toxicity. Metabolomics. 12:1–15.
   Web of Science ®Google Scholar
• Brush J, Lipnick SL, Phillips T, Sitko J, McDonald JT, McBride WH. 2007. Molecular mechanisms of late normal tissue injury. Semin Radiat Oncol. 17:121–130.
   PubMed Web of Science ®Google Scholar
• Cai XW, Shedden K, Ao X, Davis M, Fu XL, Lawrence TS, Lubman DM, Kong FM. 2010. Plasma proteomic analysis may identify new markers for radiation-induced lung toxicity in patients with non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 77:867–876.
   PubMed Web of Science ®Google Scholar
• Cai XW, Shedden KA, Yuan SH, Davis MA, Xu LY, Xie CY, Fu XL, Lawrence TS, Lubman DM, Kong FM. 2011. Baseline plasma proteomic analysis to identify biomarkers that predict radiation-induced lung toxicity in patients receiving radiation for non-small cell lung cancer. J Thorac Oncol. 6:1073–1078.
   PubMed Web of Science ®Google Scholar
• Candeias SM, Testard I. 2015. The many interactions between the innate immune system and the response to radiation. Cancer Lett. 368:173–178.
   PubMed Web of Science ®Google Scholar
• Chai Y, Wang J, Gao Y, Wang T, Shi F, Su J, Yang Y, Zhou X, Song L, Liu Z. 2015. Identification of biomarkers for radiation-induced acute intestinal symptoms (RIAISs) in cervical cancer patients by serum protein profiling. J Radiat Res. 56:134–140.
   PubMed Web of Science ®Google Scholar
• Chen GY, Nuñez G. 2010. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol. 10:826–837.
   PubMed Web of Science ®Google Scholar
• Chen JJ, Yao PL, Yuan A, Hong TM, Shun CT, Kuo ML, Lee YC, Yang PC. 2003. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer. Clin Cancer Res. 9:729–737.
   PubMed Web of Science ®Google Scholar
• Chen Y, Williams J, Ding I, Hernady E, Liu W, Smudzin T, Finkelstein JN, Rubin P, Okunieff P. 2002. Radiation pneumonitis and early circulatory cytokine markers. Semin Radiat Oncol. 12(Suppl.1):26–33.
   Web of Science ®Google Scholar
• Chendil D, Ranga RS, Meigooni D, Sathishkumar S, Ahmed MM. 2004. Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene. 23:1599–1607.
   PubMed Web of Science ®Google Scholar
• Chon BH, Loeffler JS. 2002. The effect of nonmalignant systemic disease on tolerance to radiation therapy. Oncologist. 7:136–143.
   PubMed Web of Science ®Google Scholar
• Christensen E, Pintilie M, Evans KR, Lenarduzzi M, Menard C, Catton CN, Diamandis EP, Bristow RG. 2009. Longitudinal cytokine expression during IMRT for prostate cancer and acute treatment toxicity. Clin Cancer Res. 15:5576–5583.
   PubMed Web of Science ®Google Scholar
• Chung LP, Bentley DR, Reid KB. 1985. Molecular cloning and characterization of the cDNA coding for C4b-binding protein, a regulatory protein of the classical pathway of the human complement system. Biochem J. 230:133–141.
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. 2002. Inflammation and cancer. Nature. 420:860–867.
   PubMed Web of Science ®Google Scholar
• Deloch L, Derer A, Hartmann J, Frey B, Fietkau R, Gaipl US. 2016. Modern radiotherapy concepts and the impact of radiation on immune activation. Front Oncol. 6:141.
   PubMed Web of Science ®Google Scholar
• Di Maggio FM, Minafra L, Forte GI, Cammarata FP, Lio D, Messa C, Gilardi MC, Bravata V. 2015. Portrait of inflammatory response to ionizing radiation treatment. J Inflamm. 12:14.
   Google Scholar
• Donnelly EH, Nemhauser JB, Smith JM, Kazzi ZN, Farfan EB, Chang AS, Naeem SF. 2010. Acute radiation syndrome: assessment and management. South Med J. 103:541–546.
   PubMed Web of Science ®Google Scholar
• Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. 2006. Clonogenic assay of cells in vitro. Nat Protoc. 1:2315–2319.
   PubMed Web of Science ®Google Scholar
• Garaj-Vrhovac V, Kopjar N. 2003. The alkaline comet assay as biomarker in assessment of DNA damage in medical personnel occupationally exposed to ionizing radiation. Mutagenesis. 18:265–271.
   PubMed Web of Science ®Google Scholar
• Green DR. 2000. Apoptosis and sphingomyelin hydrolysis. The flip side. J Cell Biol. 150:F5–7.
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Greten FR, Karin M. 2010. Immunity, inflammation, and cancer. Cell. 140:883–899.
   PubMed Web of Science ®Google Scholar
• Gunther S, Ostheimer C, Stangl S, Specht HM, Mozes P, Jesinghaus M, Vordermark D, Combs SE, Peltz F, Jung MP, Multhoff G. 2015. Correlation of Hsp70 serum levels with gross tumor volume and composition of lymphocyte subpopulations in patients with squamous cell and adeno non-small cell lung cancer. Front Immunol. 6:556.
   PubMed Web of Science ®Google Scholar
• Gupta T, Agarwal J, Jain S, Phurailatpam R, Kannan S, Ghosh-Laskar S, Murthy V, Budrukkar A, Dinshaw K, Prabhash K, Chaturvedi P, D’Cruz A. 2012. Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial. Radiother Oncol. 104:343–348.
   PubMed Web of Science ®Google Scholar
• Hall EJ, Giaccia AJ. 2006. Radiobiology for the radiologist. Philadelphia (PA): Lippincott Williams & Wilkins.
   Google Scholar
• Hart JP, Broadwater G, Rabbani Z, Moeller BJ, Clough R, Huang D, Sempowski GA, Dewhirst M, Pizzo SV, Vujaskovic Z, Anscher MS. 2005. Cytokine profiling for prediction of symptomatic radiation-induced lung injury. Int J Radiat Oncol Biol Phys. 63:1448–1454.
   PubMed Web of Science ®Google Scholar
• Hauer-Jensen M, Kong FM, Fink LM, Anscher MS. 1999. Circulating thrombomodulin during radiation therapy of lung cancer. Radiat Oncol Investig. 7:238–242.
   PubMedGoogle Scholar
• Herold DM, Hanlon AL, Hanks GE. 1999. Diabetes mellitus: a predictor for late radiation morbidity. Int J Radiat Oncol Biol Phys. 43:475–479.
   PubMed Web of Science ®Google Scholar
• Hopewell JW, Young CM. 1978. Changes in the microcirculation of normal tissues after irradiation. Int J Radiat Oncol Biol Phys. 4:53–58.
   PubMed Web of Science ®Google Scholar
• Hoyer KK, Dooms H, Barron L, Abbas AK. 2008. Interleukin-2 in the development and control of inflammatory disease. Immunol Rev. 226:19–28.
   PubMed Web of Science ®Google Scholar
• Jelonek K, Pietrowska M, Ros M, Zagdanski A, Suchwalko A, Polanska J, Marczyk M, Rutkowski T, Skladowski K, Clench MR, Widlak P. 2014. Radiation-induced changes in serum lipidome of head and neck cancer patients. Int J Mol Sci. 15:6609–6624.
   PubMed Web of Science ®Google Scholar
• Johansson S, Svensson H, Denekamp J. 2000. Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients. Int J Radiat Oncol Biol Phys. 48:745–750.
   PubMed Web of Science ®Google Scholar
• Karas M, Hillenkamp F. 1988. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal Chem. 60:2299–2301.
   PubMed Web of Science ®Google Scholar
• Kerns SL, Kundu S, Oh JH, Singhal SK, Janelsins M, Travis LB, Deasy JO, Janssens AC, Ostrer H, Parliament M, Usmani N, Rosenstein BS. 2015. The prediction of radiotherapy toxicity using single nucleotide polymorphism-based models: a step toward prevention. Semin Radiat Oncol. 25:281–291.
   PubMed Web of Science ®Google Scholar
• Lin C, Donaldson SS, Meza JL, Anderson JR, Lyden ER, Brown CK, Morano K, Laurie F, Arndt CA, Enke CA, Breneman JC. 2012. Effect of radiotherapy techniques (IMRT vs. 3D-CRT) on outcome in patients with intermediate-risk rhabdomyosarcoma enrolled in COG D9803–a report from the Children’s Oncology Group. Int J Radiat Oncol Biol Phys. 82:1764–1770.
   PubMed Web of Science ®Google Scholar
• Lutgens LC, Deutz NE, Gueulette J, Cleutjens JP, Berger MP, Wouters BG, von Meyenfeldt MF, Lambin P. 2003. Citrulline: a physiologic marker enabling quantitation and monitoring of epithelial radiation-induced small bowel damage. Int J Radiat Oncol Biol Phys. 57:1067–1074.
   PubMed Web of Science ®Google Scholar
• Matsushima K, Larsen CG, DuBois GC, Oppenheim JJ. 1989. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med. 169:1485–1490.
   PubMed Web of Science ®Google Scholar
• Menard C, Johann D, Lowenthal M, Muanza T, Sproull M, Ross S, Gulley J, Petricoin E, Coleman CN, Whiteley G, et al. 2006. Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis. Cancer Res. 66:1844–1850.
   PubMed Web of Science ®Google Scholar
• Neta R. 1997. Modulation with cytokines of radiation injury: suggested mechanisms of action. Environ Health Perspect. 105(Suppl.6):1463–1465.
   PubMed Web of Science ®Google Scholar
• Nylund R, Lemola E, Hartwig S, Lehr S, Acheva A, Jahns J, Hildebrandt G, Lindholm C. 2014. Profiling of low molecular weight proteins in plasma from locally irradiated individuals. J Radiat Res. 55:674–682.
   PubMed Web of Science ®Google Scholar
• Oh JH, Craft JM, Townsend R, Deasy JO, Bradley JD, El Naqa I. 2011. A bioinformatics approach for biomarker identification in radiation-induced lung inflammation from limited proteomics data. J Proteome Res. 10:1406–1415.
   PubMed Web of Science ®Google Scholar
• Overgaard J, Eriksen JG, Nordsmark M, Alsner J, Horsman MR. 2005. Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial. Lancet Oncol. 6:757–764.
   PubMed Web of Science ®Google Scholar
• Paiva B, Merino J, San Miguel JF. 2016. Utility of flow cytometry studies in the management of patients with multiple myeloma. Curr Opin Oncol. 28:511–517.
   PubMed Web of Science ®Google Scholar
• Palmblad M, Tiss A, Cramer R. 2009. Mass spectrometry in clinical proteomics – from the present to the future. Proteomics Clin Appl. 3:6–17.
   PubMed Web of Science ®Google Scholar
• Pasi F, Facoetti A, Nano R. 2010. IL-8 and IL-6 bystander signalling in human glioblastoma cells exposed to gamma radiation. Anticancer Res. 30:2769–2772.
   PubMed Web of Science ®Google Scholar
• Pernot E, Hall J, Baatout S, Benotmane MA, Blanchardon E, Bouffler S, El Saghire H, Gomolka M, Guertler A, Harms-Ringdahl M, et al. 2012. Ionizing radiation biomarkers for potential use in epidemiological studies. Mutat Res. 751:258–286.
   PubMed Web of Science ®Google Scholar
• Pietrowska M, Jelonek K, Polanska J, Wojakowska A, Marczak L, Chawinska E, Chmura A, Majewski W, Miszczyk L, Widlak P. 2015. Partial-body irradiation in patients with prostate cancer treated with IMRT has little effect on the composition of serum proteome. Proteomes. 3:117.
   PubMedGoogle Scholar
• Pietrowska M, Polanska J, Walaszczyk A, Wygoda A, Rutkowski T, Skladowski K, Marczak L, Stobiecki M, Marczyk M, Polanski A, Widlak P. 2011. Association between plasma proteome profiles analysed by mass spectrometry, a lymphocyte-based DNA-break repair assay and radiotherapy-induced acute mucosal reaction in head and neck cancer patients. Int J Radiat Biol. 87:711–719.
   PubMed Web of Science ®Google Scholar
• Pietrowska M, Widlak P. 2012. MALDI-MS-based profiling of serum proteome: detection of changes related to progression of cancer and response to anticancer treatment. Int J Proteom. 2012:10.
   Google Scholar
• Popanda O, Marquardt JU, Chang-Claude J, Schmezer P. 2009. Genetic variation in normal tissue toxicity induced by ionizing radiation. Mutat Res. 667:58–69.
   PubMed Web of Science ®Google Scholar
• Rifai N, Gillette MA, Carr SA. 2006. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol. 24:971–983.
   PubMed Web of Science ®Google Scholar
• Ros-Mazurczyk M, Jelonek K, Pietrowska M, Zagdanski A, Suchwalko A, Jastrzab T, Polanska J, Chawinska E, Majewski W, Dominczyk I, et al. 2016a. Radiotherapy-induced changes in serum lipid profile of patients with prostate or head and neck cancer. Jacobs J Radiat Oncol. 3:030.
   Google Scholar
• Ros-Mazurczyk M, Wojakowska A, Marczak L, Polanski K, Pietrowska M, Jelonek K, Dominczyk I, Hajduk A, Rutkowski T, Skladowski K, Widlak P. 2016b. Ionizing radiation affects profile of serum metabolites: increased level of 3-hydroxybutyric acid in serum of cancer patients treated with radiotherapy. Acta Biochim Pol. 63:1–5.
   PubMed Web of Science ®Google Scholar
• Rosenstein BS. 2011. Identification of SNPs associated with susceptibility for development of adverse reactions to radiotherapy. Pharmacogenomics. 12:267–275.
   PubMed Web of Science ®Google Scholar
• Rube CE, Palm J, Erren M, Fleckenstein J, Konig J, Remberger K, Rube C. 2008. Cytokine plasma levels: reliable predictors for radiation pneumonitis? PLoS One. 3:e2898.
   PubMed Web of Science ®Google Scholar
• Rubin P, Johnston CJ, Williams JP, McDonald S, Finkelstein JN. 1995. A perpetual cascade of cytokines post irradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys. 33:99–109.
   PubMed Web of Science ®Google Scholar
• Rubner Y, Muth C, Strnad A, Derer A, Sieber R, Buslei R, Frey B, Fietkau R, Gaipl US. 2014. Fractionated radiotherapy is the main stimulus for the induction of cell death and of Hsp70 release of p53 mutated glioblastoma cell lines. Radiat Oncol. 9:89.
   PubMed Web of Science ®Google Scholar
• Ruhle PF, Fietkau R, Gaipl US, Frey B. 2016. Development of a modular assay for detailed immunophenotyping of peripheral human whole blood samples by multicolor flow cytometry. IJMS. 17:1316–1344.
   Web of Science ®Google Scholar
• Schaue D, Kachikwu EL, McBride WH. 2012. Cytokines in radiobiological responses: a review. Radiat Res. 178:505–523.
   PubMed Web of Science ®Google Scholar
• Schaue D, Micewicz ED, Ratikan JA, Xie MW, Cheng G, McBride WH. 2015. Radiation and inflammation. Semin Radiat Oncol. 25:4–10.
   PubMed Web of Science ®Google Scholar
• Schlegel R, MacGregor JT, Everson RB. 1986. Assessment of cytogenetic damage by quantitation of micronuclei in human peripheral blood erythrocytes. Cancer Res. 46:3717–3721.
   PubMed Web of Science ®Google Scholar
• Shacter E, Weitzman SA. 2002. Chronic inflammation and cancer. Oncology (Williston Park, NY) 16:217–226, 229.
   PubMed Web of Science ®Google Scholar
• Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le Moan N, Grueter CA, Lim H, Saunders LR, Stevens RD, et al. 2013. Suppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science. 339:211–214.
   PubMed Web of Science ®Google Scholar
• Simonet WS, Hughes TM, Nguyen HQ, Trebasky LD, Danilenko DM, Medlock ES. 1994. Long-term impaired neutrophil migration in mice overexpressing human interleukin-8. J Clin Invest. 94:1310–1319.
   PubMed Web of Science ®Google Scholar
• Solassol J, Jacot W, Lhermitte L, Boulle N, Maudelonde T, Mange A. 2006. Clinical proteomics and mass spectrometry profiling for cancer detection. Expert Rev Proteomics. 3:311–320.
   PubMed Web of Science ®Google Scholar
• Stone HB, Coleman CN, Anscher MS, McBride WH. 2003. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol. 4:529–536.
   PubMed Web of Science ®Google Scholar
• Sykes PJ, Day TK. 2007. Requirements for identification of low dose and non-linear mutagenic responses to ionising radiation. Dose Response. 5:308–314.
   PubMedGoogle Scholar
• Taylor AM, Harnden DG, Arlett CF, Harcourt SA, Lehmann AR, Stevens S, Bridges BA. 1975. Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature. 258:427–429.
   PubMed Web of Science ®Google Scholar
• Thadikkaran L, Siegenthaler MA, Crettaz D, Queloz PA, Schneider P, Tissot JD. 2005. Recent advances in blood-related proteomics. Proteomics. 5:3019–3034.
   PubMed Web of Science ®Google Scholar
• Vaudel M, Sickmann A, Martens L. 2012. Current methods for global proteome identification. Expert Rev Proteom. 9:519–532.
   PubMed Web of Science ®Google Scholar
• Veeraraghavan J, Natarajan M, Aravindan S, Herman TS, Aravindan N. 2011. Radiation-triggered tumor necrosis factor (TNF) alpha-NFkappaB cross-signaling favors survival advantage in human neuroblastoma cells. J Biol Chem. 286:21588–21600.
   PubMed Web of Science ®Google Scholar
• Weintraub NL, Jones WK, Manka D. 2010. Understanding radiation-induced vascular disease. J Am College Cardiol. 55:1–5.
   Web of Science ®Google Scholar
• West CM, Barnett GC. 2011. Genetics and genomics of radiotherapy toxicity: towards prediction. Genome Med. 3:52.
   PubMed Web of Science ®Google Scholar
• Widlak P, Jelonek Wojakowska K, Pietrowska A, Polanska M, Marczak J, Miszczyk ŁL, Składowski K. 2015. Serum proteome signature of radiation response: upregulation of inflammation-related factors, and downregulation of apolipoproteins and coagulation factors in cancer patients subjected to radiotherapy: a pilot study. Int J Radiat Oncol Biol Phys. 92:1108–1115.
   PubMed Web of Science ®Google Scholar
• Widlak P, Pietrowska Polanska M, Rutkowski J, Jelonek T, Kalinowska-Herok K, Gdowicz-Klosok M, Wygoda A, Tarnawski AR, Skladowski K. 2013. Radiotherapy-related changes in serum proteome patterns of head and neck cancer patients; the effect of low and medium doses of radiation delivered to large volumes of normal tissue. J Transl Med. 11:299.
   PubMed Web of Science ®Google Scholar
• Widlak P, Pietrowska M, Wojtkiewicz K, Rutkowski T, Wygoda A, Marczak L, Marczyk M, Polanska J, Walaszczyk A, Dominczyk I, et al. 2011. Radiation-related changes in serum proteome profiles detected by mass spectrometry in blood of patients treated with radiotherapy due to larynx cancer. J Radiat Res. 52:575–581.
   PubMed Web of Science ®Google Scholar
• Wilson GD, Marples B. 2007. Flow cytometry in radiation research: past, present and future. Radiat Res. 168:391–403.
   PubMed Web of Science ®Google Scholar
• Withers HR, Taylor JM, Maciejewski B. 1988. Treatment volume and tissue tolerance. Int J Radiat Oncol Biol Phys. 14:751–759.
   PubMed Web of Science ®Google Scholar
• Wouters BG. 2008. Proteomics: methodologies and applications in oncology. Semin Radiat Oncol. 18:115–125.
   PubMed Web of Science ®Google Scholar
• Wulfkuhle JD, Liotta LA, Petricoin EF. 2003. Proteomic applications for the early detection of cancer. Nat Rev Cancer. 3:267–275.
   PubMed Web of Science ®Google Scholar
• Wygoda A, Maciejewski B, Skladowski K, Hutnik M, Pilecki B, Golen M, Rutkowski T. 2009. Pattern analysis of acute mucosal reactions in patients with head and neck cancer treated with conventional and accelerated irradiation. Int J Radiat Oncol Biol Phys. 73:384–390.
   PubMed Web of Science ®Google Scholar
• Yu H. 2012. Typical cell signaling response to ionizing radiation: DNA damage and extranuclear damage. Chin J Cancer Res. 24:83–89.
   PubMed Web of Science ®Google Scholar
• Zhang JS, Nakatsugawa S, Niwa O, Ju GZ, Liu SZ. 1994. Ionizing radiation-induced IL-1 alpha, IL-6 and GM-CSF production by human lung cancer cells. Chin Med J. 107:653–657.
   PubMed Web of Science ®Google Scholar
• Zhou A, Huntington JA, Pannu NS, Carrell RW, Read RJ. 2003. How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration. Nat Struct Biol. 10:541–544.
   PubMedGoogle Scholar